On March 24, the Board of Directors of Biogen authorized a program to repurchase up to $5B of the company’s common stock. The 2019 Share Repurchase Program does not have an expiration date. All share repurchases under the 2019 Share Repurchase Program will be retired. The 2019 Share Repurchase Program is in addition to the approximately $1.7B remaining under the share repurchase program authorized by the Board of Directors of the company in August 2018.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.